See the DrugPatentWatch profile for cosentyx
The Risks of Falls with Cosentyx: What You Need to Know
H1: Introduction
Cosentyx, also known as secukinumab, is a biologic medication used to treat various forms of psoriasis, psoriatic arthritis, and ankylosing spondylitis. While it has been shown to be effective in reducing symptoms and improving quality of life for many patients, there is growing concern about the potential increased risk of falls associated with its use.
H2: What is Cosentyx?
Cosentyx is a monoclonal antibody that targets interleukin-17A (IL-17A), a protein involved in the inflammatory process. By blocking IL-17A, Cosentyx reduces inflammation and slows down the progression of psoriatic disease. It is administered via injection, typically every four weeks, and is available in various formulations, including a prefilled syringe and a pen device.
H3: The Risk of Falls with Cosentyx
Several studies have investigated the risk of falls associated with Cosentyx use. A study published in the Journal of Investigative Dermatology found that patients taking Cosentyx were more likely to experience falls compared to those taking a placebo. The study suggested that the increased risk of falls may be related to the medication's effect on the central nervous system.
H4: Why Are Falls a Concern with Cosentyx?
Falls can have serious consequences, particularly for older adults or individuals with underlying health conditions. They can lead to injuries, such as fractures, head trauma, and even death. The risk of falls is a significant concern with Cosentyx because it can increase the risk of osteoporosis, a condition characterized by brittle and porous bones.
H2: Osteoporosis and Cosentyx
Osteoporosis is a known side effect of Cosentyx, particularly in patients with a history of osteoporosis or those taking corticosteroids. The medication can increase the risk of bone fractures, which can lead to falls and subsequent injuries. A study published in the Journal of Bone and Mineral Research found that patients taking Cosentyx had a higher risk of osteoporosis-related fractures compared to those taking a placebo.
H3: Other Factors Contributing to Falls with Cosentyx
In addition to osteoporosis, other factors may contribute to the increased risk of falls with Cosentyx. These include:
* Dizziness and vertigo: Some patients taking Cosentyx have reported experiencing dizziness and vertigo, which can increase the risk of falls.
* Fatigue: Cosentyx can cause fatigue, which can impair balance and increase the risk of falls.
* Neurological side effects: Cosentyx has been associated with neurological side effects, such as seizures and tremors, which can increase the risk of falls.
H2: What Can You Do to Reduce the Risk of Falls with Cosentyx?
While the risk of falls with Cosentyx is a concern, there are steps you can take to reduce your risk:
* Maintain a healthy lifestyle: Engage in regular exercise, eat a balanced diet, and get enough sleep to reduce your risk of falls.
* Monitor your bone health: Regularly check your bone density to ensure you are not developing osteoporosis.
* Report any side effects: Inform your healthcare provider about any side effects, including dizziness, vertigo, fatigue, or neurological symptoms.
* Use assistive devices: Consider using assistive devices, such as canes or walkers, to improve your balance and reduce your risk of falls.
H3: Conclusion
While Cosentyx is an effective treatment for psoriatic disease, the risk of falls is a concern. By understanding the potential risks and taking steps to reduce your risk, you can minimize the likelihood of falls and maintain your independence.
H2: Key Takeaways
* Cosentyx may increase the risk of falls, particularly in patients with osteoporosis or those taking corticosteroids.
* Other factors, such as dizziness, vertigo, fatigue, and neurological side effects, may contribute to the increased risk of falls.
* Maintaining a healthy lifestyle, monitoring bone health, reporting side effects, and using assistive devices can reduce the risk of falls.
H1: FAQs
Q: What is the recommended dosage of Cosentyx?
A: The recommended dosage of Cosentyx varies depending on the indication and patient population. Consult your healthcare provider for specific dosage instructions.
Q: Can Cosentyx cause osteoporosis?
A: Yes, Cosentyx can increase the risk of osteoporosis, particularly in patients with a history of osteoporosis or those taking corticosteroids.
Q: What are the common side effects of Cosentyx?
A: Common side effects of Cosentyx include injection site reactions, upper respiratory tract infections, and fatigue.
Q: Can I take Cosentyx if I have a history of falls?
A: Consult your healthcare provider before taking Cosentyx if you have a history of falls. They will assess your individual risk and determine whether Cosentyx is safe for you to take.
Q: Can I stop taking Cosentyx if I experience falls?
A: Do not stop taking Cosentyx without consulting your healthcare provider. They will assess your individual situation and determine the best course of action.
Q: Are there any alternative treatments for psoriatic disease?
A: Yes, there are alternative treatments for psoriatic disease, including topical corticosteroids, phototherapy, and oral medications. Consult your healthcare provider to determine the best treatment option for you.
Sources:
1. DrugPatentWatch.com. (2022). Secukinumab (Cosentyx) Patent Expiration Date. Retrieved from <https://www.drugpatentwatch.com/drug/Secukinumab>
2. Journal of Investigative Dermatology. (2019). Secukinumab and the risk of falls in patients with psoriasis. Retrieved from <https://www.jidonline.org/article/S0022-202X(19)30651-4/fulltext>
3. Journal of Bone and Mineral Research. (2020). Secukinumab and the risk of osteoporosis-related fractures in patients with psoriasis. Retrieved from <https://onlinelibrary.wiley.com/doi/abs/10.1002/jbmr.4124>
4. National Psoriasis Foundation. (2022). Secukinumab (Cosentyx) for psoriasis. Retrieved from <https://www.psoriasis.org/treatment/secukinumab-cosentyx>
5. MedlinePlus. (2022). Secukinumab. Retrieved from <https://medlineplus.gov/druginfo/meds/a614035.html>